Skip to main content

What the FDA labels say about taking them together

Drospirenone and efavirenz

Drospirenone's FDA label of August 27, 2026 names efavirenz in its drug interactions section; the efavirenz label PlainMeds reads does not name drospirenone. The drospirenone label: “Some drugs or herbal products that may decrease the effectiveness of HCs include efavirenz, phenytoin, barbiturates, carbamazepine, bosentan, felbamate, griseofulvin, oxcarbazepine, rifampicin, rifabutin, rufinamide …”

Check it at the source: the drospirenone FDA label on DailyMed (effective August 27, 2026, Exeltis USA, Inc.); the efavirenz FDA label on DailyMed (effective March 31, 2024, Cipla USA Inc.).

What does the drospirenone label say about efavirenz?

Drospirenone label, drug interactions

Some drugs or herbal products that may decrease the effectiveness of HCs include efavirenz, phenytoin, barbiturates, carbamazepine, bosentan, felbamate, griseofulvin, oxcarbazepine, rifampicin, rifabutin, rufinamide, aprepitant, and products containing St. John's wort.

Source: FDA drug label (SLYND), Exeltis USA, Inc., effective August 27, 2026 (SPL set db32bc55-f295-4d87-9dbb-0a2f45573dcf), via openFDA; the full label on DailyMed

What does the efavirenz label say about drospirenone?

Efavirenz's label (effective March 31, 2024) does not name drospirenone in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Efavirenz), Cipla USA Inc., effective March 31, 2024 (SPL set 92603fa5-7a2c-4bfb-9a70-aadb4fba952c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Drospirenone generic labelers
5Efavirenz generic labelers
DrospirenoneEfavirenz
Labeled forBirth controlHIV
Boxed warningNoNo
Pharmacy cost (NADAC)$6.61 per tablet 4 mg tablet$1.28 per tablet 600 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?